Form D · Biotechnology
CymoGen Dx, LLC
New Windsor, NY · CIK 0001495598
Offering snapshot reported Jul 6, 2010 · SEC filing
- Reported sold
- $350K Offering amount: $800K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jul 2, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 6, 2010 | Initial | $350,161 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144467
Source: Form D, filed Jul 6, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allen Goodman | Director |
| Peter Hartmayer | Director, Executive, Promoter |
| Andrew Rogal | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4 London Avenue Suite 100
New Windsor, NY, 12553
New Windsor, NY, 12553